Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 14.85%1.72B | 14.56%1.11B | 18.95%548.34M | 14.60%2.1B | 10.54%1.5B | 8.60%972.84M | 11.33%460.97M | 19.20%1.84B | 32.31%1.36B | 34.23%895.83M |
| Operating revenue | 14.85%1.72B | 14.56%1.11B | 18.95%548.34M | 14.60%2.1B | 10.54%1.5B | 8.60%972.84M | 11.33%460.97M | 19.20%1.84B | 32.31%1.36B | 34.23%895.83M |
| Total operating cost | 15.87%1.51B | 21.48%995.47M | 29.08%495.63M | 23.10%1.85B | 20.01%1.3B | 16.99%819.43M | 20.45%383.97M | 21.76%1.5B | 30.58%1.09B | 29.18%700.42M |
| Operating cost | 16.80%1.26B | 20.59%820.55M | 27.52%407.12M | 28.97%1.54B | 25.64%1.08B | 24.69%680.45M | 32.22%319.26M | 25.41%1.19B | 36.15%859.48M | 32.39%545.71M |
| Operating tax surcharges | -16.20%6.31M | -22.40%3.63M | 44.82%2.17M | 16.12%10.41M | 13.75%7.53M | 27.32%4.68M | -27.23%1.5M | -8.63%8.96M | -9.34%6.62M | -14.27%3.68M |
| Operating expense | 8.08%29.58M | 1.27%20.28M | 13.18%9.34M | -0.45%38.36M | -8.35%27.37M | 4.91%20.02M | -26.33%8.25M | -11.30%38.53M | -5.87%29.86M | -6.10%19.09M |
| Administration expense | 10.20%126.37M | 19.51%87.32M | 23.78%43.83M | -2.78%155.51M | 15.01%114.67M | 11.46%73.07M | 2.06%35.41M | 19.05%159.95M | 2.74%99.71M | 1.27%65.56M |
| Financial expense | 653.38%14.41M | 256.98%14.96M | 222.47%6.75M | -59.94%5.15M | -113.39%-2.6M | -156.16%-9.53M | -188.00%-5.51M | -44.18%12.86M | 20.03%19.44M | 67.74%16.97M |
| -Interest expense (Financial expense) | 21.85%23.2M | 29.76%15.96M | 33.91%7.77M | -18.42%25.23M | -20.14%19.04M | -21.93%12.3M | -23.64%5.8M | 45.66%30.92M | 66.05%23.84M | 83.87%15.76M |
| -Interest Income (Financial expense) | 76.48%-6.11M | 83.89%-3.94M | 86.56%-1.86M | -20.05%-27.82M | -237.16%-25.96M | -5,707.24%-24.46M | -5,009.65%-13.86M | -2,391.46%-23.17M | -1,001.37%-7.7M | -4.94%-421.25K |
| Research and development | -5.84%71.1M | -3.98%48.72M | 5.39%26.42M | 13.79%101M | 7.75%75.51M | 2.66%50.73M | 8.46%25.07M | 23.79%88.76M | 47.56%70.08M | 61.93%49.42M |
| Credit Impairment Loss | 55.47%-2.49M | 124.86%1.47M | 55.56%-881.53K | -214.14%-12.76M | -82.41%-5.58M | -33.18%-5.92M | -166.40%-1.98M | 12.31%-4.06M | -589.47%-3.06M | -169.92%-4.45M |
| Asset Impairment Loss | -309.68%-9.17M | 54.04%-1.48M | ---- | -2,107.82%-5.31M | -856.15%-2.24M | -756.17%-3.21M | 91.14%-20.11K | 98.19%-240.71K | 98.16%-234.04K | 97.05%-375.12K |
| Other net revenue | ||||||||||
| Fair value change income | 85.55%14.9M | 590.29%10.22M | --5.08M | --7.36M | --8.03M | --1.48M | ---- | ---- | ---- | ---- |
| Invest income | --4.1M | --2.02M | ---- | 870.71%6.34M | ---- | ---- | ---- | 153.43%652.77K | 315.58%281.76K | 300.41%271.48K |
| Asset deal income | -76.97%282.8K | -119.59%-465.64K | 74.09%25.22K | 67.77%-643.12K | 152.37%1.23M | 199.13%2.38M | 101.05%14.49K | -669.15%-2M | -38,716.69%-2.34M | -2,289.20%-2.4M |
| Other revenue | 45.46%11.95M | 52.23%6.77M | 50.37%4.13M | 3.39%16.89M | 2.81%8.22M | -3.08%4.45M | 143.94%2.75M | 9.81%16.34M | 82.78%7.99M | 134.87%4.59M |
| Operating profit | 12.52%231.53M | -9.87%137.52M | -21.48%61.06M | -22.45%267.61M | -24.64%205.77M | -20.96%152.58M | -17.58%77.76M | 14.08%345.07M | 47.82%273.04M | 71.08%193.05M |
| Add:Non operating Income | 607.70%6.5M | 1,174.97%2.64M | 2,124.75%2.33M | 33.82%1.21M | 135.29%918.04K | -46.96%206.94K | -67.06%104.61K | -48.68%903.49K | -74.38%390.18K | -72.95%390.18K |
| Less:Non operating expense | 8.73%799.34K | 7.36%761.06K | -25.39%54.72K | 1,554.64%1.08M | 1,109.02%735.19K | 1,366.84%708.89K | 764.33%73.34K | -92.56%65.02K | -92.25%60.81K | -92.37%48.33K |
| Total profit | 15.19%237.23M | -8.34%139.4M | -18.59%63.33M | -22.60%267.74M | -24.66%205.95M | -21.36%152.08M | -17.82%77.79M | 14.02%345.91M | 47.40%273.37M | 70.16%193.39M |
| Less:Income tax cost | 59.27%35.76M | 43.42%23.09M | -30.37%7.25M | -30.76%18.16M | -52.36%22.46M | -54.18%16.1M | -50.39%10.41M | -59.82%26.23M | -27.78%47.14M | -21.10%35.13M |
| Net profit | 9.79%201.47M | -14.46%116.31M | -16.77%56.08M | -21.93%249.58M | -18.89%183.5M | -14.08%135.98M | -8.54%67.38M | 34.27%319.68M | 88.23%226.23M | 128.94%158.26M |
| Net profit from continuing operation | 9.79%201.47M | -14.46%116.31M | -16.77%56.08M | -21.93%249.58M | -18.89%183.5M | -14.08%135.98M | -8.54%67.38M | 34.27%319.68M | 88.23%226.23M | 128.94%158.26M |
| Less:Minority Profit | -60.57%865.72K | -685.44%-1.22M | -257.54%-357.26K | 1,945.03%1.62M | 441.76%2.2M | 163.28%207.61K | 120.78%226.78K | -96.97%79.36K | -130.99%-642.42K | -5,020.13%-328.06K |
| Net profit of parent company owners | 10.64%200.6M | -13.44%117.53M | -15.95%56.44M | -22.42%247.96M | -20.09%181.3M | -14.39%135.78M | -10.18%67.15M | 35.73%319.6M | 92.08%226.87M | 129.40%158.59M |
| Earning per share | ||||||||||
| Basic earning per share | 7.14%0.15 | -10.00%0.09 | -20.00%0.04 | -34.48%0.19 | -36.36%0.14 | -37.50%0.1 | -37.50%0.05 | 20.83%0.29 | 83.33%0.22 | 128.57%0.16 |
| Diluted earning per share | 7.14%0.15 | -10.00%0.09 | -20.00%0.04 | -34.48%0.19 | -36.36%0.14 | -37.50%0.1 | -37.50%0.05 | 20.83%0.29 | 83.33%0.22 | 128.57%0.16 |
| Other composite income | -980K | |||||||||
| Other composite income of parent company owners | ---980K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total composite income | 9.26%200.49M | -14.46%116.31M | -16.77%56.08M | -21.93%249.58M | -18.89%183.5M | -14.08%135.98M | -8.54%67.38M | 34.27%319.68M | 88.23%226.23M | 128.94%158.26M |
| Total composite income of parent company owners | 10.10%199.62M | -13.44%117.53M | -15.95%56.44M | -22.42%247.96M | -20.09%181.3M | -14.39%135.78M | -10.18%67.15M | 35.73%319.6M | 92.08%226.87M | 129.40%158.59M |
| Total composite income of minority owners | -60.57%865.72K | -685.44%-1.22M | -257.54%-357.26K | 1,945.03%1.62M | 441.76%2.2M | 163.28%207.61K | 120.78%226.78K | -96.97%79.36K | -130.99%-642.42K | -5,020.13%-328.06K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.